Joseph Brown

发表

Phase I Study of TLK 286 ( Glutathione S-Transferase P 1-1 Activated Glutathione Analogue ) in Advanced Refractory Solid Malignancies 1

J. Keck, R. Lum, S. Schow, 2003 .

Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies.

J. Keck, R. Lum, S. Schow, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.